GSK Plc (Brazil) Price Prediction
| G1SK34 Stock | BRL 41.07 0.29 0.71% |
Oversold Vs Overbought
36
Oversold | Overbought |
Using GSK Plc hype-based prediction, you can estimate the value of GSK plc from the perspective of GSK Plc response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GSK Plc to buy its stock at a price that has no basis in reality. In that case, they are not buying GSK because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
GSK Plc after-hype prediction price | BRL 41.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
GSK |
GSK Plc After-Hype Price Prediction Density Analysis
As far as predicting the price of GSK Plc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GSK Plc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GSK Plc, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GSK Plc Estimiated After-Hype Price Volatility
In the context of predicting GSK Plc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GSK Plc's historical news coverage. GSK Plc's after-hype downside and upside margins for the prediction period are 39.15 and 42.99, respectively. We have considered GSK Plc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GSK Plc is very steady at this time. Analysis and calculation of next after-hype price of GSK plc is based on 3 months time horizon.
GSK Plc Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as GSK Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GSK Plc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GSK Plc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.28 | 1.92 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
41.07 | 41.07 | 0.00 |
|
GSK Plc Hype Timeline
GSK plc is currently traded for 41.07on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. GSK is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.28%. %. The volatility of related hype on GSK Plc is about 0.0%, with the expected price after the next announcement by competition of 41.07. The book value of the company was currently reported as 5.25. The company has Price/Earnings To Growth (PEG) ratio of 0.45. GSK plc recorded earning per share (EPS) of 6.69. The entity last dividend was issued on the 23rd of February 2023. The firm had 4:5 split on the 20th of July 2022. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out GSK Plc Basic Forecasting Models to cross-verify your projections.GSK Plc Related Hype Analysis
Having access to credible news sources related to GSK Plc's direct competition is more important than ever and may enhance your ability to predict GSK Plc's future price movements. Getting to know how GSK Plc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GSK Plc may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENGI11 | Energisa SA | 0.00 | 0 per month | 0.00 | (0.28) | 2.44 | (2.57) | 6.68 | |
| BTLG11 | BTG Pactual Logstica | 0.00 | 0 per month | 0.00 | (0.33) | 0.98 | (1.29) | 4.73 | |
| PLPL3 | Plano Plano Desenvolvimento | 0.00 | 0 per month | 2.46 | (0.06) | 3.33 | (3.81) | 13.45 | |
| HBTS5 | Companhia Habitasul de | 0.00 | 0 per month | 0.00 | (0.16) | 5.18 | (6.25) | 20.67 | |
| PGCO34 | The Procter Gamble | 0.00 | 0 per month | 1.01 | 0.04 | 2.19 | (1.84) | 7.52 | |
| E1RI34 | Telefonaktiebolaget LM Ericsson | 0.00 | 0 per month | 0.86 | 0.06 | 3.62 | (2.09) | 16.05 | |
| C1AB34 | Cable One | 0.00 | 0 per month | 1.68 | 0.11 | 4.00 | (2.61) | 13.73 | |
| ATMP3 | ATMA Participaes SA | 0.00 | 0 per month | 0.00 | (0.06) | 4.86 | (4.41) | 21.44 | |
| BEWZ39 | Ishares Msci Brazil | 0.00 | 0 per month | 1.44 | (0.07) | 2.06 | (2.65) | 8.19 |
GSK Plc Additional Predictive Modules
Most predictive techniques to examine GSK price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GSK using various technical indicators. When you analyze GSK charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GSK Plc Predictive Indicators
The successful prediction of GSK Plc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GSK plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GSK Plc based on analysis of GSK Plc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GSK Plc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GSK Plc's related companies.
Story Coverage note for GSK Plc
The number of cover stories for GSK Plc depends on current market conditions and GSK Plc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GSK Plc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GSK Plc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
GSK Plc Short Properties
GSK Plc's future price predictability will typically decrease when GSK Plc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GSK plc often depends not only on the future outlook of the potential GSK Plc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GSK Plc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4 B |
Complementary Tools for GSK Stock analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |